Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07007585

Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection

Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection: A Prospective Observational Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Jose Ivan Rodriguez de Molina Serrano · Academic / Other
Sex
All
Age
5 Years
Healthy volunteers
Not accepted

Summary

This 3-year prospective observational study aims to identify clinical and laboratory risk factors associated with hospitalization in patients with confirmed dengue virus infection. It also seeks to analyze real-world transfusion practices and their outcomes. The study will be conducted in a second-level hospital in northern Mexico and will follow patients from emergency department entry to clinical resolution or hospital discharge.

Detailed description

This study will prospectively follow patients over 3 years to determine the relationship between clinical/laboratory variables and outcomes such as hospitalization and transfusion need. It seeks to improve understanding of real-world decision-making in transfusions for dengue-related thrombocytopenia and refine current hospitalization criteria based on locally observed predictors. Patients will be enrolled consecutively at emergency departments or outpatient clinics with confirmed dengue infection. Clinical data (fever duration, bleeding signs, vomiting, abdominal pain, platelet count, hematocrit) and transfusion records will be collected and analyzed to identify independent predictors using multivariate logistic regression.

Conditions

Timeline

Start date
2025-08-01
Primary completion
2028-07-31
Completion
2028-08-30
First posted
2025-06-06
Last updated
2025-09-16

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT07007585. Inclusion in this directory is not an endorsement.

Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection (NCT07007585) · Clinical Trials Directory